Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
237
-
Total 13F shares, excl. options
-
32.5M
-
Shares change
-
+2.61M
-
Total reported value, excl. options
-
$2.73B
-
Value change
-
+$225M
-
Put/Call ratio
-
1.41
-
Number of buys
-
147
-
Number of sells
-
-88
-
Price
-
$83.98
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q2 2023
279 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q2 2023.
TransMedics Group, Inc. - Common Stock (TMDX) has 237 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.5M shares
of 33.9M outstanding shares and own 95.8% of the company stock.
Largest 10 shareholders include FMR LLC (3.31M shares), BlackRock Inc. (2.31M shares), LORD, ABBETT & CO. LLC (1.87M shares), VANGUARD GROUP INC (1.78M shares), MACQUARIE GROUP LTD (1.69M shares), FRED ALGER MANAGEMENT, LLC (1.65M shares), Allspring Global Investments Holdings, LLC (1.29M shares), Invesco Ltd. (1.28M shares), Driehaus Capital Management LLC (1.16M shares), and Sandhill Capital Partners LLC (813K shares).
This table shows the top 237 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.